Akunna Iheanacho, Ph.D., is the Scientific Director at Texcell North America, Inc., where she provides technical and scientific direction for novel assay development, virus purification efforts, and viral safety testing. She also serves as a Study Director for viral clearance studies. She is a subject matter expert with broad biotechnology experience and expertise in areas that include process development for large-scale cGMP manufacture of vaccines, AAV gene therapies, and biopharmaceutical purification.
Ernesto P. Chanona, Ph.D. has joined CSSi LifeScience as Director of Business Development. His role will be to find opportunities by developing strategic partnerships with innovation hubs, incubators, entrepreneurs, government agencies, and academic researchers. Some of the company’s clients are overseas, so he will be contributing to the relationship management of their global government partners. Internally, he will be part of the marketing and operations teams, helping to shape the company’s message and helping to grow the business development department.
“In Conversation” with Mina Izadjoo, President of IPS In preparation for the upcoming CEO Talks Panel on Innovators Combating Drug Resistance, BioBuzz Contributor, Sarah Ellinwood, Ph.D. caught up with one [….]
These Philosophies Have Propelled The Emmes Corporation to Become a Leading International Clinical Research Organization
These Philosophies Have Propelled The Emmes Corporation to Become a Leading International Clinical Research Organization Emmes Shows That Doing Good is Good for Science, Medicine and Business The [….]